NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines

Latest News & Postscripts

Denosumab shared care for osteoporosis

Posted: January 18, 2016.
Category - Medicines Update
Tagged with - Osteoporosis

Denosumab 60mg/1mL is a second line drug used in the treatment of osteoporosis to reduce the risk of hip, vertebral and non-vertebral fractures. It is admi...

Read More...

Anticoagulants and dental procedures

Posted: January 18, 2016.
Category - Medicines Update
Tagged with - Dabigatran Anticoagulants Antiplatelets

Anticoagulants or antiplatelets for patients undergoing dental procedures New guidance on the Management of Dental Patients Taking Anticoagulants or Antiplatelet Drugs has been p...

Read More...

Ventmax and Pulvinal discontinued

Posted: January 18, 2016.
Category - Medicines Update
Tagged with - Respiratory Asthma

There are small numbers of patients using these products. Advice on switching is given below.   Ventmax® salbutamol tablets: Inhalation route preferred for salbutamol.

Read More...

Insuman insulin shortage

Posted: January 18, 2016.
Category - Medicines Update
Tagged with - Diabetes

Sanofi have announced there will be a temporary and short-term supply shortage of Insuman® Basal pre-filled pens Insuman® Basal cartridges Insuman® Comb25 (pre-mixed insulin) pre-filled pens.

Read More...

Prescribing in Myasthenia Gravis

Posted: January 13, 2016.
Category - Medicines Update Acute
Tagged with - Pyridostigmine gentamicin

Prescribing in Myasthenia Gravis Key messages • Delay or omission of Myasthenia Gravis (MG) medicines can very quickly result in a significant worsening of the patient’s myasthen...

Read More...

Twitter and Facebook

Posted: December 28, 2015.
Category - Medicines Update

Twitter: follow us at @NHSGGCMeds or search the hashtag #ggcmedicines Facebook: search and like NHSGGC Medicines Update.   NHSGGC Medicin...

Read More...

MUE 04: PPIs

Posted: December 18, 2015.
Category - Medicines Update Extra

 Oral Proton Pump Inhibitors

  • Proton Pump Inhibitors (PPIs) are one of the most commonly prescribed classes of drug
  • PPIs are an effective treatment when used appropriately
  • PPIs should only be prescribed where there is a clear indication
  • PPIs are usually well tolerated
  • Recent evidence suggests that PPIs may have potentially serious adverse effects such as fractures, hypomagnesaemia, subacute cutaneous lupus erythematosus, pneumonia and Clostridium difficile infection

Read More...

Shared Care Protocols

Posted: December 17, 2015.
Category - Medicines Update

The Prescribing Interface Subcommittee of the Area Drug & Therapeutics Committee (ADTC) co-ordinates the formal management of prescribing issues between primary care and the acute setting including the review, approval and collation of Shar...

Read More...

New NHS Scotland Palliative Care Guidelines App

Posted: December 17, 2015.
Category - Medicines Update
Tagged with - Guidelines Update

New NHS Scotland Palliative Care Guidelines App Sixteen of the NHSScotland palliative care guidelines are now available in app format provid...

Read More...

BNF and BNF for Children (BNFC) errors

Posted: December 17, 2015.
Category - Medicines Update

BNF publications have re-designed the print and online versions of the BNF.  The first issue of the new look BNF 70 and BNFC 2015-16 were published in September 2015.  Since publication, a number of issues including dose errors have been identified. 

Read More...